DealsArchiMed buys CubeArchiMed has acquired Cube, a German developer of membrane proteins for drug discovery.ByIris Dorbian3 November 2021•3 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs